Skyline Diagnostics establishes Research Collaboration with Janssen
"We are very pleased with extension of this exciting companion diagnostic program" said Henk Viëtor, CEO of Skyline Diagnostics, "this collaboration will provide both companies the opportunity to develop a unique personalized medicine approach to help identify patients at increased risk of side effects".
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.